Cell Biotech Co., Ltd. (KOSDAQ:049960)
South Korea · Delayed Price · Currency is KRW 15,040
+60 (0.40%)
At close: Jul 21, 2026
Cell Biotech Market Cap
Cell Biotech has a market cap or net worth of 102.93 billion as of July 21, 2026. Its market cap has increased by 8.36% in one year.
Market Cap
102.93B
Enterprise Value
8.62B
Revenue
56.49B
Ranking
n/a
PE Ratio
7.67
Stock Price
15,040.00
ChartMarket Cap Chart
Since March 3, 2003, Cell Biotech's market cap has increased from 13.97B to 102.93B, an increase of 636.91%. That is a compound annual growth rate of 8.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 102.93B | 14.72% |
| Dec 30, 2025 | 89.72B | -8.13% |
| Dec 30, 2024 | 97.66B | 27.18% |
| Dec 28, 2023 | 76.79B | -11.65% |
| Dec 29, 2022 | 86.92B | -34.80% |
| Dec 30, 2021 | 133.30B | -19.84% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Y-Biologics | 153.30B |
| Bio Solution | 152.25B |
| Kanaph Therapeutics | 147.95B |
| Prestige Biologics | 143.45B |
| ISU Abxis | 129.46B |
| TiumBio | 118.05B |
| ViGenCell | 112.95B |
| NovMetaPharma | 87.32B |